Ideal peptide for cell regeneration, TB-500 peptide by Euro Pharmacies is also known as thymosin beta 4. It plays an important role in the protection, regeneration, and remodeling of injured or damaged tissue. The TB-500 gene was also identified as one of the first to respond after an injury.
Thymosin Beta(TB4) Tb-500 2 mg – Euro Pharmacies
Il prezzo originale era: $49.00.$38.00Il prezzo attuale è: $38.00.
Description
- Product and Laboratory: Thymosin Beta(TB4) Tb-500 2mg – 1 vial by Euro Pharmacies
- Form: Subcutaneous injection
- Ingredients: Thymosin Beta 4 (TB-500)
- Concentration: 2 mg / vial
- Packaging: 1 vial of 10ml
- Dosage: 2-6 mg per week
Beginners Intermediate Advanced Female 2mg/week 4mg/week 6mg/week 2mg/week - Type: Cellular regeneration cycle, reduces inflammation, improves healing
- Protection: No need for protections
- Level: Suitable for all users
Peptide TB-500 Advanced Dosage
Recommended dosage for new users:
- Normal dosage (2 mg/week)
Recommended dosage for advanced users: those who already have experience with steroids, peptides, or HGH:
- Advanced dosage = Double dose (4 mg/week)
Recommended Elite Pro dosage for Competitors and Professionals:
- Elite Pro dosage = Triple dose (6 mg/week)
- Tip: divide the injections during the day
You must be logged in to post a review.
This product is shipped worldwide from our Warehouse Euro Pharma :
- Shipping price from this warehouse: $25 (or $25 + 15% of total order with shipping insurance)
- Validation of your payment: 24 to 72 hours (except week-end) after you sent us the payment proof.
- Preparation and shipping of the parcel: within 5 work days (excluding weekend) after validation of your payment.
- Transit and delivery: 4-10 days.
- We send you the tracking code: 2 to 5 days after parcel has been shipped.
We deliver only to Belgium, Bulgaria, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, Portugal, Spain, Switzerland,United Kingdom (NO shipping to Australia, Canada and the United States.)
Reviews
There are no reviews yet.